Skip to main content

Animations

MJFF Publications

4261 - 4270 of 6458 Results
Title
Year
  • Year
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • 2019
  • 2019
  • 2023
  • Summary Details
    OPEN
    Title: Post‐Mortem Studies of Neurturin Gene Therapy for Parkinson's Disease: Two Subjects with 10 Years CERE120 Delivery
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/mds.29518
    Citation Count: 24
  • Summary Details
    OPEN
    Title: Interaction of Mitochondrial Polygenic Score and Lifestyle Factors in LRRK2 p.Gly2019Ser Parkinsonism
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/mds.29563
    Citation Count: 22
  • Wearables for Parkinson's: Fast‐Paced toward Novel Outcome Measures
    2023
    Summary Details
    OPEN
    Title: Wearables for Parkinson's: Fast‐Paced toward Novel Outcome Measures
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.29608
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Targeting Rab‐RILPL interactions as a strategy to downregulate pathogenic LRRK2 in Parkinson's disease
    Journal Name: Journal of Peptide Science
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/psc.3563
    Citation Count: 4
  • The Hypoxia Response Pathway: A Potential Intervention Target in Parkinson's Disease?
    2023
    Summary Details
    OPEN
    Title: The Hypoxia Response Pathway: A Potential Intervention Target in Parkinson's Disease?
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.29688
    Citation Count: 11
  • Summary Details
    OPEN
    Title: Targeting sleep and the circadian system as a novel treatment strategy for Parkinson’s disease
    Journal Name: Journal of Neurology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s00415-023-12073-7
    Citation Count: 13
  • Summary Details
    OPEN
    Title: Toward Omics-Scale Quantitative Mass Spectrometry Imaging of Lipids in Brain Tissue Using a Multiclass Internal Standard Mixture
    Journal Name: Analytical Chemistry
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1021/acs.analchem.3c02724
    Citation Count: 45
  • Summary Details
    OPEN
    Title: Genetic risk of Parkinson disease and progression:
    Journal Name: Neurology Genetics
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1212/nxg.0000000000000348
    Citation Count: 161
  • Summary Details
    OPEN
    Title: MAPT p.V363I mutation
    Journal Name: Neurology Genetics
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1212/nxg.0000000000000347
    Citation Count: 17
  • Summary Details
    OPEN
    Title: Long-term exposure to low-level particulate air pollution and Parkinson's disease diagnosis - A Finnish register-based study
    Journal Name: Environmental Research
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.envres.2023.115944
    Citation Count: 18
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.